Boston Scientific Corporation company logo

# 1st Gen Model Boston Scientific Corporation Surgical & medical instruments

67.92% successful of 53 deals
$26.89 Last close price
at 21-aug-2017

BSX

Model's trade recommendations -0.88% Return for period

7.83% Annual return

$36.90B Market Cap

β 1.09  

BSX

Model (following trade recommendations)

BSX

Underlying stock

S&P 500

Index
Return for period -0.88%
-2.50%
1.78%
52wk return 2.04%
11.48%
16.82%
52wk Range
20.09—28.25
2000.54—2399.63
Sortino ratio 1.33
Sharpe ratio 0.86
Norm. RMSE 0.29%
Downside risk 5.74%
Volatility 8.89%
  • STRONG BUY Analysts consensus recommendation

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for BSX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 1362M
P/E 22.79
Shares Outstanding 1372M
% Held by Insiders 0.74%
% Held by Institutions 91.62%
EPS (last reported FY) $1.11
EPS (last reported Q) $0.32
EPS, estimated (last reported Q) $0.31
Total revenues $8 B
Net income $0 B